drugset / Trial / NCT00189228

Immune Dysfunction in Allergic Asthma

NCT00189228

NaSingle-groupOpen-labelBasic science

Summary

We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.

Timeline

Start
2005-09
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Omalizumab Monoclonal antibody

Indications